Veterinary Pharmaceutical Solutions (VPS) has introduced two new compounded oral formulations, AmoxMelox and Enteriquell, designed to streamline infection control and inflammation management in swine production.
These innovations address “unique needs” in the barn by combining multiple medications into single, easy-to-administer solutions.
AmoxMelox pairs Amoxicillin and Meloxicam to target infections while simultaneously reducing inflammation in sows. For piglets, Enteriquell offers a powerful combination of Tylosin, Gentamicin, and Dexamethasone, allowing for the co-administration of antibiotics and steroids in a single oral dose. Both products are designed for precise individual dosing, simplifying treatment protocols for producers and veterinarians alike.
“As a trusted partner to livestock veterinarians for over 30 years, we are proud to bring these two new solutions to market,” says Dean Warras, CEO of VPS. “AmoxMelox and Enteriquell reflect our ongoing mission to enhance animal health, support veterinarians, and create measurable value for producers and stakeholders.”
Animal drug compounding is the process of combining, mixing, or altering drugs to create a medication tailored to the needs of an individual animal or a small group of animals. Compounded drugs must be prescribed under the care of an individual veterinarian. VPS says these drugs play a critical role in veterinary medicine when alternatives are not available. Compounding must be done from FDA-approved finished dose forms.
These prescription-only products are available exclusively through licensed veterinarians. For more information, visit VeterinaryPharmaceuticalSolutions.com.
